Pirtobrutinib, a highly selective, noncovalent (reversible) BTKi in R/R follicular lymphoma: phase 1/2 BRUIN study
Pirtobrutinib,一种高选择性、非共价(可逆)BTKi,用于治疗复发/难治性滤泡性淋巴瘤:BRUIN 1/2期研究
期刊:Blood Advances
影响因子:7.1
doi:10.1182/bloodadvances.2024014975
Shah, Nirav N; Zinzani, Pier Luigi; Wang, Michael; Nasta, Sunita D; Lech-Maranda, Ewa; Ogawa, Yoshiaki; Fakhri, Bita; Kuss, Bryone; Miyashita, Kaname; Patel, Krish; Coombs, Catherine C; Ma, Shuo; Patel, Manish R; Barve, Minal A; Tessoulin, Benoit; Stathis, Anastasios; Ennishi, Daisuke; Hashimoto, Daigo; Kojima, Kensuke; Zelenetz, Andrew D; Cohen, Jonathon B; Vose, Julie M; Maddocks, Kami J; Munir, Talha; Sun, Fangfang; Bian, Yuanyuan; Balbas, Minna; Tsai, Donald E; Abada, Paolo; Cheah, Chan Y